Skip to main content
Shionogi & Co.,Ltd. logo

Shionogi & Co.,Ltd. — Investor Relations & Filings

Ticker · 4507 ISIN · JP3347200002 LEI · 35380049VXDTHZI3DY35 T Manufacturing
Open in API
Filings indexed 76 across all filing types
Latest filing 2022-06-24 Audit Report / Informat…
Country JP Japan
Listing T 4507

About Shionogi & Co.,Ltd.

https://www.shionogi.com/global/en/

Shionogi & Co., Ltd. is a drug discovery-based pharmaceutical company that researches, develops, manufactures, and markets a portfolio of prescription drugs, over-the-counter (OTC) products, and diagnostic reagents. The company prioritizes addressing unmet medical needs, with a significant focus on infectious diseases, including antibiotics, HIV, influenza, and COVID-19. A key strategic area is the development of solutions to combat antimicrobial resistance (AMR). Historically, the company is known for the development of Crestor, a widely used statin. Shionogi aims to provide innovative products and services to improve global health outcomes.

Recent filings

Filing Released Lang Actions
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan, which accompanies the Annual Securities Report (Yukashoken Hokokusho). It confirms the accuracy of the financial statements for the 157th fiscal period. Since it is a regulatory filing required by law to accompany the annual report but is not the annual report itself, and does not fit into other specific categories like 'Audit Report' or 'Management Report', it falls under the 'Regulatory Filings' (RNS) category. FY 2022
2022-06-24 Japanese
有価証券報告書－第157期(令和3年4月1日－令和4年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains the standard cover page with the fiscal year (157th term, 2021-04-01 to 2022-03-31), company details, and XBRL tagging metadata typical of a comprehensive annual financial filing. It is not an announcement or a summary, but the full regulatory annual report. FY 2022
2022-06-24 Japanese
四半期報告書－第157期第3四半期(令和3年10月1日－令和3年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (第３四半期報告書) filed by Shionogi & Co., Ltd. with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, management analysis, and audit review information for the third quarter of the fiscal year. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-02-10 Japanese
四半期報告書－第157期第2四半期(令和3年7月1日－令和3年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Shionogi & Co., Ltd. in accordance with the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, management analysis (MDA), and operational updates for the second quarter of the 157th fiscal period (April 1, 2021, to September 30, 2021). As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report (IR). H1 2022
2021-11-11 Japanese
四半期報告書－第157期第1四半期(令和3年4月1日－令和3年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Shionogi & Co., Ltd. with the Kanto Local Finance Bureau. It contains detailed financial statements, including the Consolidated Statement of Profit or Loss, Statement of Comprehensive Income, and Statement of Financial Position for the first quarter of the 157th fiscal period (April 1, 2021, to June 30, 2021). It adheres to the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data and analysis for a period shorter than a full fiscal year. Q1 2021
2021-08-10 Japanese
内部統制報告書－第156期(令和2年4月1日－令和3年3月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act of Japan. It details the framework, scope, and results of the company's internal controls over financial reporting. Since this is a specific regulatory filing regarding internal control systems and does not fit into the other categories like 10-K or ER, it is classified as a Regulatory Filing (RNS).
2021-06-23 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.